Sign in
Lawson E. Whiting

Lawson E. Whiting

President and Chief Executive Officer at BROWN FORMAN
CEO
Executive
Board

About Lawson E. Whiting

Lawson E. Whiting, 57, has served as President and Chief Executive Officer of Brown‑Forman since 2019 and as a director since 2018, following a 28‑year career at the company spanning strategy, finance, and brand leadership roles . Under his tenure, FY2025 saw reported net sales decline 5%, operating income decline 22%, and diluted EPS decline 14% due largely to divestitures, while the company returned $420M in dividends and reported 14.4% ROIC; Brown‑Forman’s 1‑, 3‑, and 5‑year TSR trailed the S&P 500 Consumer Staples and the broader S&P 500 indices during the period shown in the proxy .

Past Roles

OrganizationRoleYearsStrategic Impact
Brown‑FormanPresident & Chief Executive Officer2019–presentOverall corporate strategy and performance; co‑chairs Brown‑Forman/Brown Family Shareholders Committee .
Brown‑FormanEVP & Chief Operating Officer2017–2019Oversight of operations and execution .
Brown‑FormanEVP & Chief Brands and Strategy Officer2015–2017Portfolio strategy and brand leadership .
Brown‑FormanSVP & Chief Brands Officer2013–2015Global brand stewardship .
Brown‑FormanSVP & Managing Director, Western Europe2011–2013Regional P&L leadership .
Brown‑FormanVP & Finance Director, Western Europe2010–2011Regional finance leadership .
Brown‑FormanVP & Finance Director, North America2009–2010Regional finance leadership .

External Roles

OrganizationRoleYearsNotes
Keurig Dr Pepper Inc. (Nasdaq: KDP)DirectorApr 2025–presentPublic company board service .
The Brown‑Forman FoundationDirectorMar 2019–presentNon‑profit foundation role .

Fixed Compensation

Multi‑year CEO compensation (SEC Summary Compensation Table):

Metric (USD)FY2023FY2024FY2025
Salary (incl. holiday bonus)$1,250,040 $1,250,040 $1,276,083
Stock Awards (PBRSUs, grant‑date fair value)$2,075,901 $4,765,947 $4,624,396
SSAR/Option Awards (grant‑date fair value)$1,786,508 $2,216,456 $2,366,441
Non‑Equity Incentive Plan Compensation (STC + LTC)$3,387,283 $3,706,929 $2,969,623
Change in Pension Value & NQDC Earnings$1,095,610 $1,145,802 $2,024,516
All Other Compensation$55,920 $108,986 $188,485
Total$9,651,262 $13,194,160 $13,449,544

CEO perquisites and other compensation detail (FY2025):

  • 401(k) match $15,542; company‑provided life insurance $2,496; car/aircraft benefits $154,725 including $120,711 personal aircraft use; other items $15,722 .
  • CEO is required to use chartered aircraft for security; personal aircraft allowance up to $125,000 annually approved by the Compensation Committee .

Performance Compensation

Short‑Term Incentive (STC) – FY2025 Design and Outcome

  • Structure: 80% company performance (underlying net sales growth, underlying operating income growth; equally weighted), 20% individual performance .
  • Company results vs grid: Underlying net sales −2% (below 0% threshold), underlying operating income −3% (threshold); company component paid 7% of target .
  • CEO STC: Target $1,650,000; actual $521,400 .
MetricWeightTargetActualPayoutNotes
Underlying Net Sales YoY40%2% (100%), 7% (200% cap)−2%Included in 7% company mix payout Non‑GAAP per Appendix A .
Underlying Operating Income YoY40%4% (100%), 11% (200% cap)−3%Included in 7% company mix payout Non‑GAAP per Appendix A .
Individual Performance20%Committee discretionUniform treatment across NEOs given restructuring contextReflected in CEO actual $521,400 “Building Better” changes impacted IPOs .

Long‑Term Incentives (FY2025 Grants; 3‑year performance period FY2025–FY2027)

  • Equity mix: 2/3 PBRSUs; 1/3 SSARs .
  • PBRSU metrics: 50% 3‑yr TSR vs S&P 500 Consumer Staples; 50% 3‑yr adjusted operating income CAGR vs same index; payout 50%–150%; floor at 50% because no time‑based RSUs .
  • SSARs: Become exercisable May 1, 2027; expire Apr 30, 2034; exercise price equals grant‑date close .
Grant (7/25/2024)Units/SharesTerms
PBRSUs (target)109,505 units; grant‑date fair value $4,624,396 3‑yr performance; vesting after certification around June 1, 2027 .
SSARs (Class B)183,445; exercise price $45.07; fair value $2,366,441 Exercisable 5/1/2027; expire 4/30/2034 .

Long‑Term Incentive Outcomes (Prior Cycle FY2023–FY2025)

  • PBRSU payout: 50% of target based on 3‑yr TSR result at 11th percentile vs S&P 500 Consumer Staples; shares issued 6/2/2025 .
  • CEO PBRSUs issued: 13,004 Class A shares for FY2023–FY2025 award .
  • Long‑term cash (final cycle; program discontinued thereafter): payout 137%; CEO amount $2,448,223 .
LTI OutcomeResult
PBRSU FY2023–FY202550% payout; TSR rank 11th percentile vs staples; CEO 13,004 Class A shares issued 6/2/2025 .
Long‑Term Cash FY2023–FY2025137% payout; CEO $2,448,223 .

Equity Ownership & Alignment

Beneficial Ownership (as of April 30, 2025)

ClassShares% of Class
Class A42,501 <1%
Class B542,775 <1%
  • No pledged shares are disclosed for Mr. Whiting; pledge footnotes in the proxy relate to other individuals (e.g., Matias Bentel and W. A. Musselman) .
  • Employee stock ownership guidelines: Brown‑Forman has no stock ownership guidelines for employees; the Committee reviews NEO ownership each year when granting stock‑based compensation .
  • Hedging/derivatives/short sales are prohibited by policy for officers and directors .

Vested vs. Unvested; Upcoming Vesting/Exercise Windows

EquityStatus as of 4/30/2025Key Dates
SSARs (older tranches)Multiple tranches exercisable (e.g., 2016–2021 grants); see Outstanding Awards table .Various expirations 2026–2031 .
SSARs 202286,430 unexercisable at 4/30/2025 ; became exercisable 5/1/2025 .Expire 4/30/2032 .
SSARs 2023101,906 unexercisable .Exercisable 5/1/2026; expire 4/30/2033 .
SSARs 2024183,445 unexercisable .Exercisable 5/1/2027; expire 4/30/2034 .
PBRSUs FY2024 grant62,243 unearned (est. 100% of target shown in table) .Anticipated vest around June 1, 2026 .
PBRSUs FY2025 grant109,505 unearned (est. 100% of target shown in table) .Anticipated vest around June 1, 2027 .

Insider selling/overhang indicators:

  • No SSAR exercises by Mr. Whiting in FY2025; 13,004 Class A shares vested from PBRSUs (2022 grant cycle) in FY2025 .
  • 2022 SSARs became exercisable 5/1/2025, creating potential exercise/sale capacity; 2023 and 2024 grants come due 2026 and 2027, respectively .

Employment Terms

  • No employment agreements for NEOs; no formal severance plan (consulting agreements may be used for transition) .
  • Change‑in‑control: No single‑trigger. On change‑in‑control, options/SSARs vest but follow original schedule; full acceleration and target cash payouts occur only upon qualifying termination within 1 year after a change‑in‑control (double‑trigger) .
  • Clawbacks: SEC 10D‑compliant recoupment policy adopted in 2023; additional 2013 recoupment policy may extend lookback to six years for fraud/misconduct .
  • Mandatory retirement age: 65 for NEOs and certain executives; Mr. Whiting is 57 .

Potential payments (as if termination occurred 4/30/2025):

ScenarioHoliday BonusSTCLTCPBRSUsSSARsDeath BenefitTotal
Voluntary Termination (retirement‑eligible)$21,284 $521,400 $2,448,223 $6,419,453 $9,410,360
Involuntary Not for Cause$21,284 $521,400 $2,448,223 $6,419,453 $9,410,360
Death$21,284 $1,650,000 $1,787,024 $6,826,951 $3,000,000 $13,285,259
Termination upon Change‑in‑Control (double‑trigger)$21,284 $1,650,000 $1,787,024 $6,826,951 $10,285,259

Treatment summaries for retirement, involuntary not for cause, death/disability, and change‑in‑control scenarios (timing, pro‑ration, vesting) are detailed in the proxy .

Board Governance

  • Board service: Director since 2018; Management Director (not independent) .
  • Committee roles: Executive Committee member (with Chair and Lead Independent Director) .
  • Other governance roles: Co‑Chair of the Brown‑Forman/Brown Family Shareholders Committee, facilitating engagement with controlling family stockholders .
  • Structure: Chair and CEO roles separated since 2007; Lead Independent Director in place since 2023 to enhance independent oversight .
  • Board transitions (2025): Marshall B. Farrer (Brown family) assumed Chair post‑Annual Meeting; Whiting remains CEO/director .
  • Attendance/independence context: Board held 5 regular meetings in FY2025; all current directors attended ≥89% of Board/committee meetings; 6 of 11 nominees deemed independent .
  • Employee directors (incl. CEO) receive no director fees .

Director compensation benchmarks and guidelines apply to non‑employee directors; 5x annual retainer stock ownership guideline for non‑employee directors (not applicable to Mr. Whiting) .

Compensation Structure Analysis

  • Pay mix: High at‑risk compensation (long‑term equity and short‑term incentives), in line with market medians targeted at 50th percentile .
  • Metric rigor and outcomes: FY2025 company STC component paid at 7% amid net sales and operating income declines; Committee applied uniform individual performance assessment due to restructuring, resulting in CEO STC of $521,400 vs $1.65M target .
  • LTI design evolution: Cash component removed beginning FY2024; equity mix now PBRSUs and SSARs; last cash cycle (FY2023–FY2025) paid at 137% .
  • PBRSU floor: 50% payout floor as a design substitute for time‑based RSUs while maintaining performance orientation; FY2023–FY2025 paid at floor due to weak relative TSR .
  • Governance safeguards: No single‑trigger CIC; clawbacks; hedging/derivatives prohibited; no repricing/backdating of options/SSARs .

Say‑on‑Pay & Shareholder Feedback

  • Last say‑on‑pay (2023): >99% approval; next say‑on‑pay expected at 2026 Annual Meeting .

Compensation Peer Group (Benchmarking)

  • 21‑company comparator group spanning consumer staples/beverages and related categories; target pay at 50th percentile .

Performance & Track Record

  • FY2025: Reported net sales −5%; operating income −22%; EPS −14% with $420M dividends returned; restructuring charges of $63M to position for growth .
  • TSR vs indices: 1‑yr −26%, 3‑yr −19%, 5‑yr −10% vs positive Consumer Staples and S&P 500 benchmarks over same periods; CEO total compensation change trended downward in FY2025 (−8%) aligned with performance .
  • 1Q FY2026: Net sales −3% (reported), +1% organic; operating income −7% (reported), +2% organic; outlook reaffirmed .
  • Capital allocation: $400M share repurchase authorization (Oct 2025), with CEO commentary signaling confidence in cash generation .

Risk Indicators & Red Flags

  • Relative TSR underperformance in PBRSU cycle (11th percentile) led to 50% payout; continued underperformance could weigh on retention if sustained, though PBRSU floor mitigates severity .
  • No employee stock ownership guidelines may modestly reduce forced equity alignment, though committee monitors ownership annually .
  • Governance mitigants: Double‑trigger CIC; robust clawbacks; hedging/derivatives ban; no option repricing; independent Compensation Committee .
  • Leadership transitions: CFO retirement announced for May 1, 2026; search underway—execution risk during transition .

Investment Implications

  • Pay‑for‑performance alignment strengthened by low FY2025 STC payout (7% company component) and 50% PBRSU cycle payout; CEO’s FY2025 compensation decreased vs FY2024, signaling downside pay sensitivity to results .
  • Near‑term selling pressure appears limited: CEO executed no SSAR exercises in FY2025; however, 2022 SSARs became exercisable on 5/1/2025 and represent optionality if performance and price recover .
  • Retention and incentives remain equity‑heavy (PBRSUs/SSARs) with relative metrics vs Consumer Staples, a constructive design if TSR and adjusted operating income relative performance improves .
  • Governance structure (separate Chair/CEO; Lead Independent Director; double‑trigger CIC; clawbacks; hedging ban) reduces governance risk; employee directors receive no board pay, aligning compensation primarily with operating performance and equity .
  • Execution watch‑items: Delivering organic growth after portfolio pruning and through restructuring (“Building Better”), absorbing CFO transition, and converting repurchase authorization and cost actions into TSR catch‑up relative to staples peers .